250 related articles for article (PubMed ID: 18645011)
21. Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.
Logsdon DP; Grimard M; Luo M; Shahda S; Jiang Y; Tong Y; Yu Z; Zyromski N; Schipani E; Carta F; Supuran CT; Korc M; Ivan M; Kelley MR; Fishel ML
Mol Cancer Ther; 2016 Nov; 15(11):2722-2732. PubMed ID: 27535970
[TBL] [Abstract][Full Text] [Related]
22. Inhibitors of APE1 redox function effectively inhibit γ-herpesvirus replication in vitro and in vivo.
Hu J; Wang Y; Yuan Y
Antiviral Res; 2021 Jan; 185():104985. PubMed ID: 33271272
[TBL] [Abstract][Full Text] [Related]
23. Exposure of Barrett's and esophageal adenocarcinoma cells to bile acids activates EGFR-STAT3 signaling axis via induction of APE1.
Bhat AA; Lu H; Soutto M; Capobianco A; Rai P; Zaika A; El-Rifai W
Oncogene; 2018 Nov; 37(46):6011-6024. PubMed ID: 29991802
[TBL] [Abstract][Full Text] [Related]
24. Apurinic/Apyrimidinic endonuclease 1 regulates inflammatory response in macrophages.
Jedinak A; Dudhgaonkar S; Kelley MR; Sliva D
Anticancer Res; 2011 Feb; 31(2):379-85. PubMed ID: 21378315
[TBL] [Abstract][Full Text] [Related]
25. Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer.
Fishel ML; Xia H; McGeown J; McIlwain DW; Elbanna M; Craft AA; Kaimakliotis HZ; Sandusky GE; Zhang C; Pili R; Kelley MR; Jerde TJ
Mol Cancer Ther; 2019 Nov; 18(11):1947-1960. PubMed ID: 31413178
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of apurinic/apyrimidinic endonuclease I's redox activity revisited.
Zhang J; Luo M; Marasco D; Logsdon D; LaFavers KA; Chen Q; Reed A; Kelley MR; Gross ML; Georgiadis MM
Biochemistry; 2013 Apr; 52(17):2955-66. PubMed ID: 23597102
[TBL] [Abstract][Full Text] [Related]
27. Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival.
Logsdon DP; Shah F; Carta F; Supuran CT; Kamocka M; Jacobsen MH; Sandusky GE; Kelley MR; Fishel ML
Sci Rep; 2018 Sep; 8(1):13759. PubMed ID: 30214007
[TBL] [Abstract][Full Text] [Related]
28. Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2.
Fishel ML; Wu X; Devlin CM; Logsdon DP; Jiang Y; Luo M; He Y; Yu Z; Tong Y; Lipking KP; Maitra A; Rajeshkumar NV; Scandura G; Kelley MR; Ivan M
J Biol Chem; 2015 Jan; 290(5):3057-68. PubMed ID: 25492865
[TBL] [Abstract][Full Text] [Related]
29. Chemical Inhibition of Apurinic-Apyrimidinic Endonuclease 1 Redox and DNA Repair Functions Affects the Inflammatory Response via Different but Overlapping Mechanisms.
Oliveira TT; Fontes-Dantas FL; de Medeiros Oliveira RK; Pinheiro DML; Coutinho LG; da Silva VL; de Souza SJ; Agnez-Lima LF
Front Cell Dev Biol; 2021; 9():731588. PubMed ID: 34616737
[TBL] [Abstract][Full Text] [Related]
30. Apurinic/apyrimidinic endonuclease 1 alters estrogen receptor activity and estrogen-responsive gene expression.
Curtis CD; Thorngren DL; Ziegler YS; Sarkeshik A; Yates JR; Nardulli AM
Mol Endocrinol; 2009 Sep; 23(9):1346-59. PubMed ID: 19460860
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of APE1/Ref-1 redox activity with APX3330 blocks retinal angiogenesis in vitro and in vivo.
Jiang A; Gao H; Kelley MR; Qiao X
Vision Res; 2011 Jan; 51(1):93-100. PubMed ID: 20937296
[TBL] [Abstract][Full Text] [Related]
32. Ref-1/APE1 as a Transcriptional Regulator and Novel Therapeutic Target in Pediatric T-cell Leukemia.
Ding J; Fishel ML; Reed AM; McAdams E; Czader MB; Cardoso AA; Kelley MR
Mol Cancer Ther; 2017 Jul; 16(7):1401-1411. PubMed ID: 28446640
[TBL] [Abstract][Full Text] [Related]
33. APE1/Ref-1 redox function contributes to inflammatory pain sensitization.
Zaky A; Bouali-Benazzouz R; Favereaux A; Tell G; Landry M
Exp Neurol; 2018 Sep; 307():1-11. PubMed ID: 29772245
[TBL] [Abstract][Full Text] [Related]
34. Novel small-molecule inhibitor of apurinic/apyrimidinic endonuclease 1 blocks proliferation and reduces viability of glioblastoma cells.
Bapat A; Glass LS; Luo M; Fishel ML; Long EC; Georgiadis MM; Kelley MR
J Pharmacol Exp Ther; 2010 Sep; 334(3):988-98. PubMed ID: 20504914
[TBL] [Abstract][Full Text] [Related]
35. Reduced expression of DNA repair and redox signaling protein APE1/Ref-1 impairs human pancreatic cancer cell survival, proliferation, and cell cycle progression.
Jiang Y; Zhou S; Sandusky GE; Kelley MR; Fishel ML
Cancer Invest; 2010 Nov; 28(9):885-95. PubMed ID: 20919954
[TBL] [Abstract][Full Text] [Related]
36. The redox function of APE1 is involved in the differentiation process of stem cells toward a neuronal cell fate.
Domenis R; Bergamin N; Gianfranceschi G; Vascotto C; Romanello M; Rigo S; Vagnarelli G; Faggiani M; Parodi P; Kelley MR; Beltrami CA; Cesselli D; Tell G; Beltrami AP
PLoS One; 2014; 9(2):e89232. PubMed ID: 24586617
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of Ape1 Redox Activity Promotes Odonto/osteogenic Differentiation of Dental Papilla Cells.
Chen T; Liu Z; Sun W; Li J; Liang Y; Yang X; Xu Y; Yu M; Tian W; Chen G; Bai D
Sci Rep; 2015 Dec; 5():17483. PubMed ID: 26639148
[TBL] [Abstract][Full Text] [Related]
38. Mad2 haploinsufficiency protects hematopoietic progenitor cells subjected to cell-cycle stress in vivo and to inhibition of redox function of Ape1/Ref-1 in vitro.
Rohrabaugh SL; Hangoc G; Kelley MR; Broxmeyer HE
Exp Hematol; 2011 Apr; 39(4):415-23. PubMed ID: 21216274
[TBL] [Abstract][Full Text] [Related]
39. Knock-in reconstitution studies reveal an unexpected role of Cys-65 in regulating APE1/Ref-1 subcellular trafficking and function.
Vascotto C; Bisetto E; Li M; Zeef LA; D'Ambrosio C; Domenis R; Comelli M; Delneri D; Scaloni A; Altieri F; Mavelli I; Quadrifoglio F; Kelley MR; Tell G
Mol Biol Cell; 2011 Oct; 22(20):3887-901. PubMed ID: 21865600
[TBL] [Abstract][Full Text] [Related]
40. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.
Fishel ML; Kelley MR
Mol Aspects Med; 2007; 28(3-4):375-95. PubMed ID: 17560642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
